Dolutegravir
Back to searchMolecule Structure
Scientific Name
Dolutegravir
Description of the Drug
Dolutegravir is an antiviral agent used for the treatment of HIV-1 infections in combination with other antiretroviral agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08930
http://www.drugbank.ca/drugs/DB08930
Brand Name(s)
Tivicay
Company Owner(s)
Viiv Healthcare Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 integrase | SINGLE PROTEIN | INHIBITOR | CHEMBL3471 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL82071 | ||
PharmGKB | PA166114961 | ||
DrugBank | DB08930 | ||
PubChem: Thomson Pharma | 96100998 | ||
PubChem | 54726191 | ||
Nikkaji | J3.008.741K | ||
PDBe | DLU | ||
BindingDB | 50062551 | ||
DrugCentral | 4805 | ||
Brenda | 230559 | ||
ChemicalBook | CB62538916 | ||
Guide to Pharmacology | 7365 | ||
rxnorm | TIVICAY | DOLUTEGRAVIR SODIUM | DOLUTEGRAVIR |
PubChem: Drugs of the Future | 123055423 | ||
ChEBI | 76010 | ||
ZINC | ZINC000058581064 |